School of Medicine
Showing 1-10 of 394 Results
-
Raj Fadadu
Casual - Non-Exempt, Epidemiology and Population Health
BioRaj Fadadu is currently in his final year of medical school at the University of California, San Francisco (UCSF) School of Medicine and interested in pursuing a career in dermatology.
He has experience conducting epidemiology research projects, particularly related to environmental exposures and skin diseases (e.g., atopic dermatitis and psoriasis) and epigenetics (e.g., EWAS and epigenetic age acceleration). He also holds leadership roles in local and national organizations involved in climate change advocacy and education, working to improve community and patient health. In addition, he is a strong advocate for health equity and increasing access to medical care for people experiencing homelessness and has implemented innovative projects to do so while serving as an Albert Schweitzer Fellow and Director of student-run free clinics in Berkeley, CA. For his impactful work, he was named an Environmental Education "30 Under 30" in 2022 and received the Excellence in Climate Leadership Award from the American Public Health Association in 2022 and Emerging Physician Leader Award from Health Care Without Harm in 2021.
He received a M.S. degree in Health and Medical Sciences (with concentrations in Environmental Research and Healthcare Management) from the UC Berkeley School of Public Health and received a B.A. degree in Public Health from UC Berkeley (graduated with Highest Distinction and Research Honors). -
Robert Michael Fairchild
Clinical Assistant Professor, Medicine - Immunology & Rheumatology
Current Research and Scholarly InterestsDr. Fairchild’s research interests center on novel applications of ultrasonography in rheumatologic disease. Current active research endeavors include using ultrasound 1) to evaluate articular and soft tissue manifestations of systemic sclerosis, 2) to screen, detect and monitor of connective tissue disease associated interstitial lung disease, 3) and to examine the incidence of immune checkpoint inhibitor related adverse events and inflammatory arthritis.
